MedPath

Mobile phone in oral cancer detection in rural settings

Not Applicable
Conditions
Health Condition 1: K132- Leukoplakia and other disturbancesof oral epithelium, including tongueHealth Condition 2: K135- Oral submucous fibrosis
Registration Number
CTRI/2023/09/057181
Lead Sponsor
ational Institutes of Health, United States
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. ALl individuals above 18 years and having Clinically suspicious oral lesions which are indicated for biopsy.

Exclusion Criteria

1. Individuals less than 18 years

2. Pregnant women

3. Individuals currently undergoing treatment for malignancy

4. Individuals having acute illness or undergoing treatment for tuberculosis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The proposed dual mode intraoral imaging system will deliver new & imperatively <br/ ><br>needed capabilities to the end users in low resource setting. This artificial intelligence <br/ ><br>integrated system will: (1) detect suspicious regions with high sensitivity & specificity; <br/ ><br>(2) enable automatic, accurate, & objective in situ diagnosis; & in screening program <br/ ><br>settings or nodal center settings, the device will triage suspicious or non-suspicious <br/ ><br>lesions. <br/ ><br>Timepoint: 1. Optimize a mobile imaging system for low-resource setting in year 1 <br/ ><br>2. Develop mobile based deep learning image classification in year 1 <br/ ><br>3. Validate the clinical usefulness of the mobile imaging system in year 2
Secondary Outcome Measures
NameTimeMethod
Final outcome of the study is to achieve Diagnostic sensitivity & specificity of: 1) 95 <br/ ><br>% for distinguishing OSCC from healthy sites; (2) 90% for distinguishing OPML from <br/ ><br>healthy tissues; and (3) 85% for distinguishing non-neoplastic lesion from healthy, oral cancer, or OPML tissues.Timepoint: The diagnostic accuracy, sensitivity & specificity will be achieved at the end of second year
© Copyright 2025. All Rights Reserved by MedPath